Sequence variation in proprotein convertase subtilisin/kexin type 9 serine protease gene, low LDL cholesterol, and cancer incidence
- PMID: 18006936
- DOI: 10.1158/1055-9965.EPI-07-0502
Sequence variation in proprotein convertase subtilisin/kexin type 9 serine protease gene, low LDL cholesterol, and cancer incidence
Abstract
Some prospective epidemiologic studies have suggested that a low plasma cholesterol level may be associated with increased risk of cancer. Certain sequence variants in the proprotein convertase subtilisin/kexin type 9 serine protease gene (PCSK9) are associated with lifelong low total and LDL cholesterol. We therefore analyzed the association of PCSK9 variation with incidence of cancer between 1987 and 2000 in a prospective study (n=13,250). The frequency of the PCSK9 variants studied was 2.4% in blacks and 3.2% in whites. Neither was associated with increased cancer incidence: age- and sex-adjusted hazard ratios were 0.66 [95% confidence interval (95% CI), 0.31-1.39] in blacks and 0.77 (95% CI, 0.54-1.09) in whites. Low baseline total or LDL cholesterol levels in 1987 to 1989 were also not statistically significantly associated with incident cancer: multivariable-adjusted hazard ratios for the lowest compared with the highest quartiles of LDL cholesterol were 1.05 (95% CI, 0.78-1.40) in blacks and 1.16 (95% CI, 0.99-1.36) in whites. These data suggest that a lifelong low cholesterol concentration, as reflected by these PCSK9 variants, does not increase risk of cancer.
Similar articles
-
Sequence variations in PCSK9, low LDL, and protection against coronary heart disease.N Engl J Med. 2006 Mar 23;354(12):1264-72. doi: 10.1056/NEJMoa054013. N Engl J Med. 2006. PMID: 16554528
-
Serum proprotein convertase subtilisin/kexin type 9 concentration is not increased by plant stanol ester consumption in normo- to moderately hypercholesterolaemic non-obese subjects. The BLOOD FLOW intervention study.Clin Sci (Lond). 2015 Sep;129(5):439-46. doi: 10.1042/CS20150193. Epub 2015 Apr 10. Clin Sci (Lond). 2015. PMID: 25857271 Clinical Trial.
-
ABO blood group in relation to plasma lipids and proprotein convertase subtilisin/kexin type 9.Nutr Metab Cardiovasc Dis. 2015 Apr;25(4):411-7. doi: 10.1016/j.numecd.2014.10.015. Epub 2014 Nov 5. Nutr Metab Cardiovasc Dis. 2015. PMID: 25466598
-
PCSK9 gene mutations and low-density lipoprotein cholesterol.Clin Chim Acta. 2014 Apr 20;431:148-53. doi: 10.1016/j.cca.2014.01.043. Epub 2014 Feb 8. Clin Chim Acta. 2014. PMID: 24518357 Review.
-
Targeting the proprotein convertase subtilisin/kexin type 9 for the treatment of dyslipidemia and atherosclerosis.J Am Coll Cardiol. 2013 Oct 15;62(16):1401-8. doi: 10.1016/j.jacc.2013.07.056. Epub 2013 Aug 21. J Am Coll Cardiol. 2013. PMID: 23973703 Review.
Cited by
-
Serum PCSK9 levels at the second nivolumab cycle predict overall survival in elderly patients with NSCLC: a pilot study.Cancer Immunol Immunother. 2019 Aug;68(8):1351-1358. doi: 10.1007/s00262-019-02367-z. Epub 2019 Jul 20. Cancer Immunol Immunother. 2019. PMID: 31327024 Free PMC article.
-
Coming Back to Physiology: Extra Hepatic Functions of Proprotein Convertase Subtilisin/Kexin Type 9.Front Physiol. 2020 Dec 7;11:598649. doi: 10.3389/fphys.2020.598649. eCollection 2020. Front Physiol. 2020. PMID: 33364976 Free PMC article. Review.
-
Proprotein convertase subtilisin/kexin type 9 deficiency reduces melanoma metastasis in liver.Neoplasia. 2012 Dec;14(12):1122-31. doi: 10.1593/neo.121252. Neoplasia. 2012. PMID: 23308045 Free PMC article.
-
A case-control study on the effect of Apolipoprotein E genotypes on gastric cancer risk and progression.BMC Cancer. 2012 Oct 25;12:494. doi: 10.1186/1471-2407-12-494. BMC Cancer. 2012. PMID: 23098561 Free PMC article.
-
Potential anti-tumor effect of a nanoliposomal antiPCSK9 vaccine in mice bearing colorectal cancer.Arch Med Sci. 2019 May;15(3):559-569. doi: 10.5114/aoms.2019.84732. Epub 2019 Apr 30. Arch Med Sci. 2019. PMID: 31110520 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous